Investing.com -- L’Oreal SA (EPA:OREP) announced Monday it will acquire an additional 10% stake in Galderma Group AG (SIX:GALD), doubling its ownership to 20% as the beauty giant strengthens its position in the aesthetics market.
The French cosmetics company is purchasing the additional shares from a consortium led by EQT, which includes Sunshine SwissCo GmbH, Abu Dhabi Investment Authority, and Auba Investment Pte. Ltd.
The financial terms of the transaction were not disclosed.
Following this increased investment, Galderma’s board will consider nominating two non-independent board candidates from L’Oréal to replace the EQT consortium representatives at the 2026 Annual General Meeting.
"Aesthetics is a key adjacency to our core beauty business that we are keen to continue to explore. Our initial strategic investment made in 2024 in Galderma has proven very successful and therefore we are eager to solidify and extend the partnership further," said Nicolas Hieronimus, Chief Executive Officer of L’Oréal.
The transaction will be implemented through an off-market block trade with the EQT-led consortium. L’Oréal plans to fund the acquisition with available cash and credit lines, with closing expected by Q1-2026, subject to regulatory approvals.
L’Oréal stated it will continue to support Galderma’s strategy and independence under CEO Flemming Ørnskov and is not planning to increase its stake further. The companies will explore strengthening their existing scientific partnership to leverage their complementary expertise.
Following completion, L’Oréal will consolidate its stake in Galderma under the equity method. The previously established shareholder undertaking between L’Oréal and SSCO will be dissolved upon completion.








